Halozyme Therapeutics shares owned by Captrust Financial Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Captrust Financial Advisors
from 13F filings
Historical chart of Captrust Financial Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Captrust Financial Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Captrust Financial Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $3.8M | 57k | 67.30 |
| 2025-09-30 | $3.5M | 48k | 73.34 |
| 2025-06-30 | $2.6M | 49k | 52.02 |
| 2025-03-31 | $2.2M | 35k | 63.81 |
| 2024-12-31 | $1.4M | 30k | 47.81 |
| 2024-09-30 | $1.4M | 24k | 57.24 |
| 2024-06-30 | $1.4M | 26k | 52.36 |
| 2024-03-31 | $1.1M | 27k | 40.68 |
| 2023-12-31 | $1.0M | 28k | 36.96 |
| 2023-09-30 | $1.0M | 26k | 38.20 |
| 2022-12-31 | $262k | 4.6k | 56.90 |
| 2022-06-30 | $172k | 3.9k | 44.08 |
| 2022-03-31 | $135k | 3.4k | 40.01 |
| 2021-12-31 | $131k | 3.2k | 40.34 |
| 2021-09-30 | $118k | 2.9k | 40.72 |
| 2021-06-30 | $117k | 2.6k | 45.26 |
| 2021-03-31 | $108k | 2.6k | 41.73 |
| 2020-12-31 | $83k | 2.0k | 42.46 |
| 2020-09-30 | $45k | 1.7k | 26.47 |
| 2020-06-30 | $47k | 1.7k | 27.65 |
| 2019-09-30 | $26k | 1.7k | 15.29 |
| 2019-06-30 | $29k | 1.7k | 17.06 |
| 2019-03-31 | $27k | 1.7k | 15.88 |
| 2018-12-31 | $25k | 1.7k | 14.71 |
| 2018-09-30 | $31k | 1.7k | 18.24 |
More positions owned by Captrust Financial Advisors
View all positions for Captrust Financial Advisors